DRKS00022054已完成不适用
CovidCare 1 – Surveillance and care for confirmed and suspected patients with COVID-19 in general practice: an observational study - CovidCare - 1
niversitätsklinikum Heidelberg0 个研究点目标入组 200 人开始时间: 2020年6月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. COVID-19 patients aged 18 or older (as per definition patients with symptoms of an infect of any severity and positive test for SARS-CoV-2), who are in domestic isolation* and who have at least one risk factor*
- •2. Patients aged 50 and older with a clinically urgent suspicion of COVID-19 (such as acute respiratory symptoms of any severity), without verification of SARS-CoV-2 and who have at least one risk factor**/***
- •*Domestic isolation: includes persons for whom the authorities highly recommend further social distancing beyond the restrictions as currently ordered until April 20th 2020.
- •**This criterium might by subject to potential changes and might be further adapted according to a) the current epidemiological situation, b) the requirements of the RKI, c) the test strategy as well as d) the test capacity.
- •***Risk factors following the definition by the RKI, with own additions:
- •- Diabetes mellitus (Types I and II)
- •- Cardiovascular disease (arterial hypertension, coronary heart disease, heart failure, other such as atrial fibrillation, peripheral artery disease, condition after apoplexy)
- •- Pulmonary disease (COPD, bronchial asthma, other)
- •- chronical nephrological disease
- •- chronical hepatic disease such as liver cirrhosis
- •- immunodeficiency due to underlying disease (malignant primary hematological disease (e.g. leukemia/ lymphoma), leukocyptopenia, condition after organ or stem cell transplantation or potentially immunosuppressive medication intake such as glucocorticoids, immunosuppressive drugs, immunomodulators, cytostatics
- •- active oncological disease with immunodeficiency (excluding for example localized skin cancer such as squamous cell carcinoma or basal cell carcinoma)
- •- obesity (body mass index > 35)
- •- active smoking
- •- down syndrome
排除标准
- •incapability of informed consent
研究者
相似试验
招募中
不适用
COVID-19 Critical Care Consortium Observational Study Incorporating the Extracorporeal Membrane Oxygenation for 2019 Novel Coronavirus Acute Respiratory Disease (ECMOCARD)2019 SARS-CoV-2 Infection and coronavirus disease (COVID-19)Respiratory InfectionInfection - Studies of infection and infectious agentsRespiratory - Other respiratory disorders / diseasesACTRN12620000421932Extracorporeal Life Support Organisation10,000
进行中（未招募）
不适用
Control y seguimiento de pacientes infectados por VIH-1 en tratamiento antirretroviral y en programa de mantenimiento con metadona - Estudio CometaVIH positivos en programa de mantenimiento con metadonaEUCTR2005-000307-33-ESSogaisida
已完成
不适用
COVID-19: assessment, surveillance and testing in students´accomodationsInfection with SARS-CoV-2 (COVID-19)U07.1COVID-19, virus identifiedDRKS00024143St. Josef Hospital BochumMed. Klinik I810
尚未招募
不适用
Continuous monitoring of patients in and after the acute admission ward to optimize clinical pathwayspatiënten die voor verschillende redenen op de acute opname afdeling komenpatients in the Acute Admission WardNL-OMON51219Rijnstate Ziekenhuis800
招募中
不适用
Rapidly applicable surveillance process for COVID-19 in day care centers with dual swabs 2U07.1COVID-19, virus identifiedDRKS00024117Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main1,500